Hydromorphone Hydrochloride 00641-6151
Product NDC
00641-6151- Manufacturer
- Hikma Pharmaceuticals Usa Inc.
- Dosage Form
- Injection
- Route
- Intramuscular, Intravenous, And Subcutaneous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- July 1, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA202159
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hydromorphone Hydrochloride | 2 mg/mL |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Packaging Options(1)
25 VIAL, SINGLE-DOSE in 1 CARTON (0641-6151-25) / 1 mL in 1 VIAL, SINGLE-DOSE (0641-6151-01)